Showing 481 - 500 results of 668 for search '"inflammatory bowel disease"', query time: 0.06s Refine Results
  1. 481

    Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature by Joseph J. LaConti, Jean A. Donet, Jeong Hee Cho-Vega, Daniel A. Sussman, Dana Ascherman, Amar R. Deshpande

    Published 2016-01-01
    “…Tumor necrosis factor-α (TNFα) inhibitor therapy has signified an important milestone in the fight against many rheumatological disorders and inflammatory bowel disease (IBD). Cutaneous adverse events caused by this class of medications are well known but relatively uncommon. …”
    Get full text
    Article
  2. 482

    Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response by Guo Liu, Feng Liu

    Published 2022-01-01
    “…Genome-wide association studies have identified various susceptibility loci of Bach2 which are linked with Th2 inflammatory diseases such as asthma and inflammatory bowel disease. Here, we discuss the critical role of Bach2 involved in the Th2 immune response and associated inflammatory diseases.…”
    Get full text
    Article
  3. 483

    Iron Deficiency Anaemia Caused by Nonspecific (Idiopathic) Small Bowel Ulceration: An Uncommon Presentation of an Uncommon Disease by Gabriele Capurso, Edith Lahner, Nadia Pallotta, Francesco Panzuto, Gianfranco Delle Fave, Bruno Annibale

    Published 2002-01-01
    “…Ulcers of the small bowel are rare, and in most cases are due to infections, inflammatory bowel diseases, malignancies or drugs. When none of these causes is recognized, they are classified as ‘nonspecific’ or idiopathic. …”
    Get full text
    Article
  4. 484

    Functional Analysis of Monkeypox and Interrelationship between Monkeypox and COVID-19 by Bioinformatic Analysis by Eun Jung Sohn

    Published 2023-01-01
    “…KEGG analysis of 212 DEGs of GSE36854 and GSE21001 for monkeypox infection showed involvement of monkeypox in COVID-19, cytokine-cytokine receptor interaction, inflammatory bowel disease, atherosclerosis, TNF signaling, and T cell receptor signaling. …”
    Get full text
    Article
  5. 485

    Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis by Fadhel A. Abdullah, Maha A. Mahmood

    Published 2024-12-01
    “… Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract (GIT) it includes two-condition Crohn’s disease (CD) and ulcerative colitis (UC) the prolonged inflammation may cause invasion of the multiple layers of the intestinal walls result in GIT damage. …”
    Get full text
    Article
  6. 486

    Case report: A co-existing case of ulcerative colitis and dysferlinopathy in a male patient by Limin Li, Qiong Yan, Mingming Deng, Muhan Lü, Tiejun Zhou, Xiaolin Zhong

    Published 2025-01-01
    “…Patients with inflammatory bowel disease (IBD) are at risk of developing malnutrition, severe dystrophic muscle weakness, and muscle atrophy. …”
    Get full text
    Article
  7. 487

    The Role of IL-33 in Gut Mucosal Inflammation by Luca Pastorelli, Carlo De Salvo, Maurizio Vecchi, Theresa T. Pizarro

    Published 2013-01-01
    “…In 2010, four different research groups consistently described the upregulation of IL-33 in patients with inflammatory bowel disease (IBD). Animal models of IBD were subsequently utilized in order to mechanistically determine the precise role of IL-33 in chronic intestinal inflammation, without, however, reaching conclusive evidence demonstrating whether IL-33 is pathogenic or protective. …”
    Get full text
    Article
  8. 488

    The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course by Jessica Mwinyi, Christa Grete-Wenger, Jyrki J. Eloranta, Gerd A. Kullak-Ublick

    Published 2012-01-01
    “…We aimed at determining the occurring PPARγ SNPs, at predicting the haplotypes, and at determining the frequency outcome in inflammatory bowel disease (IBD) patients in comparison with healthy controls. …”
    Get full text
    Article
  9. 489

    Clinical Onset of Celiac Disease after an Episode of Campylobacter jejuni Enteritis by EF Verdu, M Mauro, J Bourgeois, D Armstrong

    Published 2007-01-01
    “…Infectious gastroenteritis is a well-established risk factor for the development of IBS, and there is recent evidence that it could play a role in the initiation and exacerbation of inflammatory bowel disease. The present case suggests that the clinical expression of CD can be unmasked by an acute gastrointestinal infection and supports the hypothesis that environmental factors other than gliadin may play a role in the clinical onset of CD in a genetically susceptible host. …”
    Get full text
    Article
  10. 490

    A Burkitt's Lymphoma Case Mimicking Crohn's Disease: A Case Report by Gulbanu Erkan, Mehmet Çoban, Aysun Çalıskan, Gokçe Kaan Ataç, Kamil Gulpınar, Bulent Degertekin, Atilla Korkmaz

    Published 2011-01-01
    “…Particularly gastrointestinal lymphomas can be clinically confused with other gastrointestinal tumors as well as with diffuse and inflammatory bowel disease. Early diagnosis and treatment bear vital importance in the management of lymphomas due to their high proliferation rates. …”
    Get full text
    Article
  11. 491

    The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis by Xiang-Tian Meng, Yun-Yue Shi, Hong Zhang, Hong-Yan Zhou

    Published 2020-01-01
    “…Studies have shown that Th17 cells are involved in a variety of immune inflammation, including psoriasis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and asthma. …”
    Get full text
    Article
  12. 492

    Antigen Presentation in the Gut by W Doe, P Pavli

    Published 1990-01-01
    “…Taken together, the aberrant expression of class II MHC molecules, breaches in epithelial cell integrity (resulting m exposure to luminal antigens including endotoxin and the increased numbers of monocytes found 10 inflamed mucosa suggest that the resulting distortions in antigen presentation contribute to the localization and persistence of the inflammatory lesion in inflammatory bowel disease.…”
    Get full text
    Article
  13. 493

    IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis by Muhammad Babar Khawar, Muddasir Hassan Abbasi, Nadeem Sheikh

    Published 2016-01-01
    “…It was found to induce the expression of various inflammatory cytokines including TNF-α, IL-6, and IL-1β as well as macrophage inflammatory protein-2 (MIP-2) and has been reported previously to be involved in the pathogenesis and progression of a number of inflammatory disorders, namely, inflammatory bowel disease (IBD), gastric inflammation and cancer, rheumatoid arthritis, and chronic obstructive pulmonary disease (COPD). …”
    Get full text
    Article
  14. 494
  15. 495

    Laparoscopic Surgery for Recurrent Crohn's Disease by Antonino Spinelli, Matteo Sacchi, Piero Bazzi, Nicoletta Leone, Silvio Danese, Marco Montorsi

    Published 2012-01-01
    “…Laparoscopy experienced a slower diffusion in inflammatory bowel disease surgery than in oncologic colorectal surgery, but proved to be safe and effective, and is currently considered the gold standard for the treatment of primary uncomplicated ileocolic CD. …”
    Get full text
    Article
  16. 496

    Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases by Nargish Parvin, Sang Woo Joo, Tapas K. Mandal

    Published 2025-01-01
    “…We discuss the underlying mechanisms of stimuli-responsive nanomaterials, recent applications in treating diseases such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, and the design considerations essential for clinical translation. …”
    Get full text
    Article
  17. 497

    Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis by Keyu Ren, Chunming Yong, Yanchun Jin, Shanwei Rong, Kuijin Xue, Bin Cao, Hongyun Wei

    Published 2025-02-01
    “…Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by persistent inflammation of the colon. …”
    Get full text
    Article
  18. 498

    CONDITIONS OF SKIN AND INTESTINE MICROBIOTES IN PATIENTS WITH PSORIASIS by Ya.O. Yemchenko, K.E. Ishcheikin, I.P. Kaidashev, G.Yu. Morokhovets

    Published 2022-04-01
    “…Changes in the intestinal microbiome in psoriasis are similar to those observed in patients with inflammatory bowel disease. Changes in the microbiome associated with psoriasis can induce an inflammatory response by activating the cytokines IL-23, IL-17 and IL-22, as well as modulating gamma-interferon and inhibiting the production of T-regulatory cells. …”
    Get full text
    Article
  19. 499

    Immune Thrombocytopenic Purpura (ITP) as an Uncommon Extraintestinal Complication of Crohn’s Disease: Case Vignette and Systematic Literature Review by Raisa Epistola, Tiffanie Do, Ritika Vankina, Daniel Wu, James Yeh, Michael W. Fleischman, Jennifer M. Lee

    Published 2020-01-01
    “…While the association of immune thrombocytopenic purpura (ITP) and inflammatory bowel disease (IBD) has been described in a few case reports, management of ITP as an extraintestinal manifestation of Crohn’s disease (CD) is less studied. …”
    Get full text
    Article
  20. 500

    PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature by Amanda Ramos, Marcela del Carmen, Oladapo Yeku

    Published 2020-01-01
    “…A review of the scientific literature reveals several cases of the successful use of immune checkpoint inhibitors in patients with autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease. Conclusion. This is one of the first reports of a patient with an underlying autoimmune vasculitis successfully treated with an immune checkpoint inhibitor without exacerbating her underlying autoimmune condition. …”
    Get full text
    Article